Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast|Neoplasm Malignant|Female
Interventions: DRUG: Palbociclib|DRUG: Letrozole 2.5mg|DRUG: Fulvestrant
Sponsor: Istituti Clinici Scientifici Maugeri SpA